Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group
Author:
Funder
Japan Agency for Medical Research and Development
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference26 articles.
1. Therapy with direct-acting antiviral agents for hepatitis C-related liver cirrhosis;N Toshikuni;Gut Liver,2017
2. Impact of interferon therapy after curative treatment of hepatocellular carcinoma;M Kudo;Oncology,2008
3. Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis;S Breitenstein;Br J Surg,2009
4. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach;YC Shen;J Hepatol,2010
5. Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma;Y Miyake;J Viral Hepat,2010
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents;Journal of Gastroenterology and Hepatology;2024-04-11
2. Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients;Journal of the Chinese Medical Association;2024-01-05
3. Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal;Hepatoma Research;2023
4. Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful;Journal of Viral Hepatitis;2022-12-12
5. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma;World Journal of Hepatology;2022-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3